ODTX
Odyssey Therapeutics, Inc.
Set alert
19.54 USD -0.29 -1.46%
19.12 Day range 20.20
15.56 52-week range 28.76
- YTD
- +19.00%
- 1 year
- +19.00%
- Open
- 19.77
- Prev close
- 19.83
- Mkt cap
- 939.06M
- Vol
- 166.40K
- Avg vol
- 262.12K
- EPS
- -7.55
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 19.12
- High
- 20.20
- Forward P/E
- -4.78
- Beta
- 0.00
- Short ratio
- 11.58
- Inst. own
- 83.08%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 4, 2026
- 50-d avg
- 22.53
- 200-d avg
- 19.92
- 1y target
- 35.75
Ownership
Held by insiders 6.19%
Held by institutions 83.08%
Float held by institutions 88.56%
Institutions 61
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| FMR, LLC | 10.78% | 5,179,262 | 107.94M | Jun 29, 2026 |
| SR One Capital Management, LP | 7.90% | 3,794,883 | 79.09M | Jun 29, 2026 |
| TPG GP A, LLC | 7.68% | 3,690,146 | 76.90M | Jun 29, 2026 |
| Lightspeed Management Company, L.L.C. | 7.51% | 3,608,443 | 75.20M | Jun 29, 2026 |
| Orbimed Advisors LLC. | 6.24% | 3,001,198 | 62.54M | Jun 29, 2026 |
| Sanofi | 4.14% | 1,991,918 | 41.51M | Jun 29, 2026 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Fidelity Mt. Vernon Street Trust-Fidelity Growth Company Fund | 2.15% | 1,033,434 | 21.54M | Jul 30, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 1.11% | 531,096 | 11.07M | Jun 29, 2026 |
| Fidelity Select Portfolios-Select Biotechnology Portfolio | 0.71% | 339,500 | 7.08M | Jul 30, 2026 |
| Fidelity Mt. Vernon Street Trust-Fidelity Growth Company K6 Fund | 0.60% | 288,662 | 6.02M | Jul 30, 2026 |
| Fidelity Mt. Vernon Street Trust-Fidelity Series Growth Company Fund | 0.52% | 249,100 | 5.19M | Jul 30, 2026 |
| T. Rowe Price Health Sciences Fund, Inc. | 0.38% | 182,547 | 3.80M | Jun 29, 2026 |
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| CHU SHELLEY | Director | Purchase | May 10, 2026 | 11,111 |
| DIMENSION CAPITAL II, L.P. | Beneficial Owner of more than 10% of a Class of Security | Purchase | May 7, 2026 | 0 |
| GLICK GARY D. PH.D. | Chief Executive Officer | Conversion of Exercise of derivative security | May 10, 2026 | 415,973 |
| HAAS JASON | Chief Financial Officer | Purchase | May 7, 2026 | 62,908 |
| LEIDEN JEFFREY M | Director | Conversion of Exercise of derivative security | May 10, 2026 | 0 |
| LI NAN LN | Director | Purchase | May 10, 2026 | 0 |
Held by funds
41 US ETFs and mutual funds hold ODTX · largest positions